For research use only. Not for therapeutic Use.
2’-Deoxy-N3-methylcytidine hydriodide is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Catalog Number | I040901 |
CAS Number | 79043-77-9 |
Synonyms | 1-[(2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one;hydroiodide |
Molecular Formula | C10H16IN3O4 |
Purity | ≥95% |
InChI | InChI=1S/C10H15N3O4.HI/c1-12-8(11)2-3-13(10(12)16)9-4-6(15)7(5-14)17-9;/h2-3,6-7,9,11,14-15H,4-5H2,1H3;1H/t6-,7-,9-;/m1./s1 |
InChIKey | DFGPJCYBYINQQK-JJVRHELESA-N |
SMILES | CN1C(=N)C=CN(C1=O)C2CC(C(O2)CO)O.I |
Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |